246 related articles for article (PubMed ID: 29358859)
1. Astragaloside IV inhibits pathological functions of gastric cancer-associated fibroblasts.
Wang ZF; Ma DG; Zhu Z; Mu YP; Yang YY; Feng L; Yang H; Liang JQ; Liu YY; Liu L; Lu HW
World J Gastroenterol; 2017 Dec; 23(48):8512-8525. PubMed ID: 29358859
[TBL] [Abstract][Full Text] [Related]
2. Triptonide inhibits the pathological functions of gastric cancer-associated fibroblasts.
Wang Z; Ma D; Wang C; Zhu Z; Yang Y; Zeng F; Yuan J; Liu X; Gao Y; Chen Y; Jia Y
Biomed Pharmacother; 2017 Dec; 96():757-767. PubMed ID: 29049979
[TBL] [Abstract][Full Text] [Related]
3. Paeoniflorin Inhibits Migration- and Invasion-Promoting Capacities of Gastric Cancer Associated Fibroblasts.
Wang ZF; Ma DG; Wang L; Feng L; Fu JW; Li Y; Wang DT; Jia YF
Chin J Integr Med; 2019 Nov; 25(11):837-844. PubMed ID: 30361813
[TBL] [Abstract][Full Text] [Related]
4. Astragaloside IV inhibits the invasion and metastasis of SiHa cervical cancer cells via the TGF‑β1‑mediated PI3K and MAPK pathways.
Zhang L; Zhou J; Qin X; Huang H; Nie C
Oncol Rep; 2019 May; 41(5):2975-2986. PubMed ID: 30896841
[TBL] [Abstract][Full Text] [Related]
5. The gastric mucosal protective effects of astragaloside IV in mnng-induced GPL rats.
Cai T; Zhang C; Zhao Z; Li S; Cai H; Chen X; Cai D; Liu W; Yan Y; Xie K; Pan H; Zeng X
Biomed Pharmacother; 2018 Aug; 104():291-299. PubMed ID: 29775897
[TBL] [Abstract][Full Text] [Related]
6. Astragaloside IV promotes the proliferation and migration of osteoblast-like cells through the hedgehog signaling pathway.
Guo LH; Cao Y; Zhuang RT; Han Y; Li J
Int J Mol Med; 2019 Feb; 43(2):830-838. PubMed ID: 30535481
[TBL] [Abstract][Full Text] [Related]
7. Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling.
Jiang K; Lu Q; Li Q; Ji Y; Chen W; Xue X
Int Immunopharmacol; 2017 Jan; 42():195-202. PubMed ID: 27930970
[TBL] [Abstract][Full Text] [Related]
8. Astragaloside IV inhibits migration and invasion in human lung cancer A549 cells via regulating PKC-α-ERK1/2-NF-κB pathway.
Cheng X; Gu J; Zhang M; Yuan J; Zhao B; Jiang J; Jia X
Int Immunopharmacol; 2014 Nov; 23(1):304-13. PubMed ID: 25218161
[TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV inhibits pathological functions of gastric cancer-associated fibroblasts through regulation of the HOXA6/ZBTB12 axis.
Liu H; Luo S; Sha X; Chen Z; Yang D
Acta Pharm; 2023 Sep; 73(3):423-439. PubMed ID: 37708965
[TBL] [Abstract][Full Text] [Related]
10. Astragaloside IV Induced miR-134 Expression Reduces EMT and Increases Chemotherapeutic Sensitivity by Suppressing CREB1 Signaling in Colorectal Cancer Cell Line SW-480.
Ye Q; Su L; Chen D; Zheng W; Liu Y
Cell Physiol Biochem; 2017; 43(4):1617-1626. PubMed ID: 29041002
[TBL] [Abstract][Full Text] [Related]
11. Protective role of astragaloside IV in gastric cancer through regulation of microRNA-195-5p-mediated PD-L1.
Liu W; Chen H; Wang D
Immunopharmacol Immunotoxicol; 2021 Aug; 43(4):443-451. PubMed ID: 34124983
[TBL] [Abstract][Full Text] [Related]
12. The healing and anti-scar effects of astragaloside IV on the wound repair in vitro and in vivo.
Chen X; Peng LH; Li N; Li QM; Li P; Fung KP; Leung PC; Gao JQ
J Ethnopharmacol; 2012 Feb; 139(3):721-7. PubMed ID: 22143155
[TBL] [Abstract][Full Text] [Related]
13. Astragaloside IV antagonizes M2 phenotype macrophage polarization-evoked ovarian cancer cell malignant progression by suppressing the HMGB1-TLR4 axis.
Wang X; Gao S; Song L; Liu M; Sun Z; Liu J
Mol Immunol; 2021 Feb; 130():113-121. PubMed ID: 33308900
[TBL] [Abstract][Full Text] [Related]
14. Astragaloside IV inhibits metastasis in hepatoma cells through the suppression of epithelial-mesenchymal transition via the Akt/GSK-3β/β-catenin pathway.
Qin CD; Ma DN; Ren ZG; Zhu XD; Wang CH; Wang YC; Ye BG; Cao MQ; Gao DM; Tang ZY
Oncol Rep; 2017 Mar; 37(3):1725-1735. PubMed ID: 28112375
[TBL] [Abstract][Full Text] [Related]
15. Raddeanin A induces human gastric cancer cells apoptosis and inhibits their invasion in vitro.
Xue G; Zou X; Zhou JY; Sun W; Wu J; Xu JL; Wang RP
Biochem Biophys Res Commun; 2013 Sep; 439(2):196-202. PubMed ID: 23988447
[TBL] [Abstract][Full Text] [Related]
16. Astragaloside IV inhibits proliferation and promotes apoptosis in rat vascular smooth muscle cells under high glucose concentration in vitro.
Yuan W; Zhang Y; Ge Y; Yan M; Kuang R; Zheng X
Planta Med; 2008 Aug; 74(10):1259-64. PubMed ID: 18622899
[TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV reverses MNNG-induced precancerous lesions of gastric carcinoma in rats: Regulation on glycolysis through miRNA-34a/LDHA pathway.
Zhang C; Cai T; Zeng X; Cai D; Chen Y; Huang X; Gan H; Zhuo J; Zhao Z; Pan H; Li S
Phytother Res; 2018 Jul; 32(7):1364-1372. PubMed ID: 29577459
[TBL] [Abstract][Full Text] [Related]
18. Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway.
Pan MS; Wang H; Ansari KH; Li XP; Sun W; Fan YZ
J Exp Clin Cancer Res; 2020 Nov; 39(1):234. PubMed ID: 33153467
[TBL] [Abstract][Full Text] [Related]
19. Astragaloside IV inhibits cell proliferation of colorectal cancer cell lines through down-regulation of B7-H3.
Wang S; Mou J; Cui L; Wang X; Zhang Z
Biomed Pharmacother; 2018 Jun; 102():1037-1044. PubMed ID: 29710520
[TBL] [Abstract][Full Text] [Related]
20. Quantitative proteomics analysis of differentially expressed proteins induced by astragaloside IV in cervical cancer cell invasion.
Xia C; He Z; Cai Y
Cell Mol Biol Lett; 2020; 25():25. PubMed ID: 32265995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
